Innovative Paradigms for ART: Implementation Insights From an Expert Panel

Download All
Learn about new paradigms for ART, including two-drug ART regimens and injectable long-acting ART, as a panel of faculty debates the most pressing questions in the field, exploring what the data say, what clinicians think, and what patients want.
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Program Director
Andrea Mantsios, PhD
Anthony M. Mills, MD
Omar Sued, MD, PhD
Babafemi Taiwo, MBBS

Downloadable Slideset

Download slide highlights from our live symposium.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD
Program Director
Andrea Mantsios, PhD Anthony M. Mills, MD Omar Sued, MD, PhD Babafemi Taiwo, MBBS
Released: July 19, 2019

FAQ Module

Learn from expert faculty as they respond to the most pressing questions on evolving paradigms in ART, including two-drug regimens and long-acting injectable therapy.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD
Program Director
Andrea Mantsios, PhD Anthony M. Mills, MD Omar Sued, MD, PhD Babafemi Taiwo, MBBS
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: September 24, 2019 Expired: No longer available for credit

Download slide highlights of expert faculty responses to the most pressing clinician questions on novel ART.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD
Program Director
Andrea Mantsios, PhD Anthony M. Mills, MD Omar Sued, MD, PhD Babafemi Taiwo, MBBS
Released: September 24, 2019

Video Module

Watch this on-demand Webcast of a CCO symposium at IAS 2019 to gain expert perspectives on evolving paradigms in ART, including two-drug regimens and long-acting injectable therapy. Learn from an international faculty panel as they engage in detailed discussions about novel ART approaches.

ClinicalThought

Current HIV guidelines limit their recommendations for dual ART, but I expect positive data will soon change this.

Omar Sued, MD, PhD Released: September 20, 2019

The question of which patients are candidates for long-acting ART might be a question of which patients want it.

Andrea Mantsios, PhD Released: September 27, 2019

Less frequent dosing may be a welcome theme among HIV drugs under investigation.

Babafemi Taiwo, MBBS Released: October 10, 2019

Why I believe as many as 70% of my patients will be interested in long-acting injectable ART.

Anthony M. Mills, MD Released: December 11, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue